Source comparison
Tesamorelin + Ipamorelin Blend Quality Real vs Fake: Comparison
This table compares authentic research-grade tesamorelin + ipamorelin blends against common counterfeit and low-quality versions across critical verification, safety, and performance dimensions. Synthesis Method Solid-phase peptide synthesis (SPPS) under ISO 7
This comparison does not assign a generated winner or score.
- This table compares authentic research-grade tesamorelin + ipamorelin blends against common counterfeit and low-quality versions across critical verification, safety, and performance dimensions.
- Synthesis Method
- Solid-phase peptide synthesis (SPPS) under ISO 7+ cleanroom conditions with sterile lyophilization
- Unknown origin; often pre-made powder repackaged without sterile protocol verification
- SPPS with cleanroom synthesis is non-negotiable for contamination control. Counterfeit peptides lack this infrastructure entirely
- HPLC Purity
- ≥98% verified by third-party lab with batch-specific CoA including test date, lab name, and contact info
- No verifiable CoA, recycled CoAs from other batches, or in-house testing with no independent verification
- Third-party HPLC at 98%+ purity is the only reliable quantitative standard; anything less introduces dosing uncertainty and contamination risk
- Batch Traceability
- Batch number on vial matches CoA; synthesis date within 6 months; traceable to specific production run
- Generic or missing batch numbers; CoA test dates more than 12 months old; no linkage between vial and documentation
- Batch traceability allows quality issue identification and recall management. Absence of this means zero accountability
- Endotoxin Testing
- <10 EU/mg verified via LAL (Limulus Amebocyte Lysate) test per USP standards
- No endotoxin testing or results not disclosed; risk of bacterial contamination from non-sterile production
- Endotoxins cause immune activation and injection site reactions; untested products introduce significant safety risk
- Reconstitution Behavior
- Dissolves completely in 60–90 seconds forming clear, colorless solution; remains stable 28 days at 2–8°C
- Slow dissolution, persistent cloudiness, visible particles, or precipitate formation within 7 days post-reconstitution
- Dissolution speed and solution clarity directly correlate with peptide purity; aggregation signals degraded or impure synthesis
- Regulatory Compliance
- FDA 503B registration or state-licensed compounding pharmacy; facility inspection records publicly available
- No regulatory registration; operates outside FDA or state oversight; no facility inspections
- Regulatory oversight ensures adherence to sterility, quality control, and adverse event reporting standards. Unregulated suppliers skip all of this
- Supplier Transparency
- Provides CoA before purchase; discloses third-party lab contact info; answers technical synthesis questions with specificity
- Refuses to share CoA proactively; provides vague or contradictory technical answers; avoids lab verification questions
- Transparency is the strongest signal of quality control confidence; evasiveness indicates the seller doesn't control or verify the supply chain
- Price Range (per 10mg blend)
- $180–$280 depending on supplier scale and shipping logistics
- $40–$120; pricing significantly below market suggests underdosing or quality shortcuts
- Peptide synthesis and third-party testing have fixed costs; prices below $150 per 10mg blend typically indicate compromised quality or fraudulent concentration